Shigella Isolates From the Global Enteric Multicenter Study Inform Vaccine Development

نویسندگان

  • Sofie Livio
  • Nancy A. Strockbine
  • Sandra Panchalingam
  • Sharon M. Tennant
  • Eileen M. Barry
  • Mark E. Marohn
  • Martin Antonio
  • Anowar Hossain
  • Inacio Mandomando
  • John B. Ochieng
  • Joseph O. Oundo
  • Shahida Qureshi
  • Thandavarayan Ramamurthy
  • Boubou Tamboura
  • Richard A. Adegbola
  • Mohammed Jahangir Hossain
  • Debasish Saha
  • Sunil Sen
  • Abu Syed Golam Faruque
  • Pedro L. Alonso
  • Robert F. Breiman
  • Anita K. M. Zaidi
  • Dipika Sur
  • Samba O. Sow
  • Lynette Y. Berkeley
  • Ciara E. O'Reilly
  • Eric D. Mintz
  • Kousick Biswas
  • Dani Cohen
  • Tamer H. Farag
  • Dilruba Nasrin
  • Yukun Wu
  • William C. Blackwelder
  • Karen L. Kotloff
  • James P. Nataro
  • Myron M. Levine
چکیده

BACKGROUND Shigella, a major diarrheal disease pathogen worldwide, is the target of vaccine development. The Global Enteric Multicenter Study (GEMS) investigated burden and etiology of moderate-to-severe diarrheal disease in children aged <60 months and matched controls without diarrhea during 3 years at 4 sites in Africa and 3 in Asia. Shigella was 1 of the 4 most common pathogens across sites and age strata. GEMS Shigella serotypes are reviewed to guide vaccine development. METHODS Subjects' stool specimens/rectal swabs were transported to site laboratories in transport media and plated onto xylose lysine desoxycholate and MacConkey agar. Suspect Shigella colonies were identified by biochemical tests and agglutination with antisera. Shigella isolates were shipped to the GEMS Reference Laboratory (Baltimore, MD) for confirmation and serotyping of S. flexneri; one-third of isolates were sent to the Centers for Disease Control and Prevention for quality control. RESULTS Shigella dysenteriae and S. boydii accounted for 5.0% and 5.4%, respectively, of 1130 Shigella case isolates; S. flexneri comprised 65.9% and S. sonnei 23.7%. Five serotypes/subserotypes comprised 89.4% of S. flexneri, including S. flexneri 2a, S. flexneri 6, S. flexneri 3a, S. flexneri 2b, and S. flexneri 1b. CONCLUSIONS A broad-spectrum Shigella vaccine must protect against S. sonnei and 15 S. flexneri serotypes/subserotypes. A quadrivalent vaccine with O antigens from S. sonnei, S. flexneri 2a, S. flexneri 3a, and S. flexneri 6 can provide broad direct coverage against these most common serotypes and indirect coverage against all but 1 (rare) remaining subserotype through shared S. flexneri group antigens.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

λ-Red-Recombineering Live Attenuated ΔipaD Shigella dysenteriae from Iranian Isolates as A Candidate of Vaccine

Shigella species (spp.) are gram-negative bacteria that are responsible for shigellosis. Although it can be controlled via antibiotics, increasing number of antibiotic resistant isolates of Shigella have been reported. Therefore, other strategies such as production of specific vaccine against this organism could be a suitable therapeutic approach. Attenuated live vaccines produced by gene delet...

متن کامل

Enteroinvasive Escherichia coli May Account for Uncultured Shigella

A recent article by Lindsay and others reported that stool quantitative polymerase chain reaction (qPCR), with a 14,000 copy number cutoff, identified more cases of Shigella infection than conventional and widely used culture methods. The authors suggested that there may be a significant underestimation of the contribution of Shigella to diarrheal disease because of the limits of culture and ha...

متن کامل

Growth inhibition of enteric pathogens by zinc sulfate: an in vitro study.

OBJECTIVE To determine the inhibition effect of zinc sulfate on isolates of enteric bacteria. MATERIALS AND METHODS Mueller-Hinton agar containing different concentrations of zinc sulfate was prepared. Isolates used in this study were obtained from local clinics. They were Salmonella typhi, Salmonella groups A, B, C, D and E, Escherichia coli, Enterobacter, Shigella and Vibrio cholerae. Overn...

متن کامل

Monoclonal Antibodies to Shigella Lipopolysaccharide Are Useful for Vaccine Production.

There is a significant need for an effective multivalent Shigella vaccine that targets the most prevalent serotypes. Most Shigella vaccines under development utilize serotype-specific lipopolysaccharides (LPSs) as a major component based on protection and epidemiological data. As vaccine formulations advance from monovalent to multivalent, assays and reagents need to be developed to accurately ...

متن کامل

Changing trends and serotype distribution of Shigella species in Beijing from 1994 to 2010

Shigella species are a common cause of acute diarrheal disease in China. In this study, we characterized the changing trends and serotype distribution of Shigella species in Beijing from 1994 to 2010. A total of 5999 Shigella strains were isolated and serotyped from the 302nd Hospital in Beijing. The annual number of Shigella isolates reached a peak (n = 1192; 19.84%) in 1996 and then decreased...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره 59  شماره 

صفحات  -

تاریخ انتشار 2014